Ixazomib, 99.85%
cas: 1072833-77-2 — see every product listed under this CAS number, including other names
Ixazomib, 99.85% (CAS 1072833-77-2) is a chemical reagent available from Chemat. Available pack sizes: 25 mg, 100 mg, 5 mg, 50 mg, 10mM/1mL, 10 mg. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-10453-25 mg |
| cas | 1072833-77-2 |
| size | 25 mg |
| availability | In stock |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 25 mg | 1633.94 Pln | |
| MedChemExpress | 100 mg | 3997.74 Pln | |
| MedChemExpress | 5 mg | 691.21 Pln | |
| MedChemExpress | 50 mg | 2544.17 Pln | |
| MedChemExpress | 10mM/1mL | 746.94 Pln | |
| MedChemExpress | 10 mg | 876.97 Pln |
properties
| delivery time | 1-2 weeks |
|---|---|
| purity | 99.85% |
Ixazomib is a glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of [(1R)-1-amino-3-methylbutyl]boronic acid. The active metabolite of ixazomib citrate, it is used in combination therapy for treatment of multiple myeloma. It has a role as an antineoplastic agent, a drug metabolite, a proteasome inhibitor, an apoptosis inducer and an orphan drug. It is a member of benzamides, a dichlorobenzene, a glycine derivative and a member of boronic acids.
Source: ChEBI
| Molecular formula | C14H19BCl2N2O4 |
|---|---|
| Molecular weight | 361.0 g/mol |
| IUPAC name | [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid |
| InChIKey | MXAYKZJJDUDWDS-LBPRGKRZSA-N |
| SMILES | B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O |
Computed by PubChem (NCBI)
Synonyms:
Ixazomib, [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid, [(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid, ixazomibum, ((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)boronic acid, ((1R)-1-(2-((2,5-dichlorophenyl)formamido)acetamido)-3-methylbutyl)boronic acid, (R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid, (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid, Ixazomib [INN], Ixozamib